Fundraising Fox
Nick Goldner
InvestorFounderVenture Partner at Alix Ventures · CEO at ResistanceBio
San Francisco Bay Area
Writes $200K – $300K checks · typically $250K
FoundedResistanceBio · YC
Find your path to Nick
Sign up to see every warm intro you have to Nick
- Paths you didn't know you had: your email and LinkedIn already hold routes to Nick. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
About
Nick Goldner is a founder and investor with a PhD in Molecular and Cellular Biology from Washington University in St. Louis, where he identified the molecular drug target of the antibiotic Daptomycin. He founded Viosera Therapeutics, an antibiotic company where he led IP strategy resulting in issued patents across the US, EU, China, and Japan, and later founded resistanceBio, an oncology services company. He now serves as a Venture Partner at Alix Ventures, focusing on early-stage life science and TechBio startups, and was previously a venture partner at Pioneer Fund covering biotech.
Contact· published on Nick's own website
Invests in
AI & Machine LearningBiotechHealthtech
CEO at ResistanceBioYC W19
Intro paths
Nick went through Y Combinator (Winter 2019) — any YC alum in your network can reach them through the YC community.
In turn, Nick can intro founders to ResistanceBio's investors below.
ResistanceBio's investors · 19
Co-founders at ResistanceBio
Colleagues at Alix Ventures
Frequently asked questions
- Who is Nick Goldner?
- Nick Goldner is a founder and investor with a PhD in Molecular and Cellular Biology from Washington University in St. Louis, where he identified the molecular drug target of the antibiotic Daptomycin. He founded Viosera Therapeutics, an antibiotic company where he led IP strategy resulting in issued patents across the US, EU, China, and Japan, and later founded resistanceBio, an oncology services company. He now serves as a Venture Partner at Alix Ventures, focusing on early-stage life science and TechBio startups, and was previously a venture partner at Pioneer Fund covering biotech.
- Where does Nick Goldner work?
- Nick Goldner is CEO of ResistanceBio and Venture Partner at Alix Ventures.
- What does Nick Goldner invest in?
- Nick Goldner invests in AI & Machine Learning, Biotech, Healthtech.
- What check size does Nick Goldner write?
- Nick Goldner typically writes checks of $200K – $300K.
- What companies did Nick Goldner found?
- Nick Goldner founded ResistanceBio.
Founder mafias
Y Combinator mafia10,635
Also came through, then founded or led a company.
Washington University School of Medicine in St. Louis mafia14
Also came through, then founded or led a company.
Alix Ventures mafia8
Also came through, then founded or led a company.
ResistanceBio mafia3
Also came through, then founded or led a company.
Viosera mafia2
Also came through, then founded or led a company.
About this profile. Compiled from public sources — Alix Ventures's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights